Alastair Harris-Cartwright
Nessuna posizione attualmente
Profilo
Mr. Alastair Harris-Cartwright is a Manager-Corporate Communications at Ontario Genomics Institute (Private Equity).
Mr. Harris-Cartwright joined OGI in January 2009.
Prior to joining OGI, he worked in public relations consultancies managing media relations and corporate communications programs for GlaxoSmithKline, private health providers and the National Health Service in the United Kingdom, where he lived before relocating to Toronto.
Mr. Harris-Cartwright holds an honours BA in Political Science and International Relations from the University of Westminster.
Precedenti posizioni note di Alastair Harris-Cartwright
Società | Posizione | Fine |
---|---|---|
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Vendite & Marketing | - |
Formazione di Alastair Harris-Cartwright
University of Westminster | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Alastair Harris-Cartwright